Batista, E.K.; Lima, L.M.A.d.; Gomes, D.A.; Crans, D.C.; Silva, W.E.; Belian, M.F.; Lira, E.C.
Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice. Pharmaceuticals 2024, 17, 760.
https://doi.org/10.3390/ph17060760
AMA Style
Batista EK, Lima LMAd, Gomes DA, Crans DC, Silva WE, Belian MF, Lira EC.
Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice. Pharmaceuticals. 2024; 17(6):760.
https://doi.org/10.3390/ph17060760
Chicago/Turabian Style
Batista, Eucilene K., Lidiane M. A. de Lima, Dayane A. Gomes, Debbie C. Crans, Wagner E. Silva, Mônica F. Belian, and Eduardo C. Lira.
2024. "Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice" Pharmaceuticals 17, no. 6: 760.
https://doi.org/10.3390/ph17060760
APA Style
Batista, E. K., Lima, L. M. A. d., Gomes, D. A., Crans, D. C., Silva, W. E., Belian, M. F., & Lira, E. C.
(2024). Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice. Pharmaceuticals, 17(6), 760.
https://doi.org/10.3390/ph17060760